These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9772065)

  • 41. Laboratory diagnosis of resistance to activated protein C (APC-resistance).
    Bertina RM
    Thromb Haemost; 1997 Jul; 78(1):478-82. PubMed ID: 9198200
    [No Abstract]   [Full Text] [Related]  

  • 42. Oral contraceptive-induced ischemic bowel disease.
    Parker WA; Morris ME; Shearer CA
    Am J Hosp Pharm; 1979 Aug; 36(8):1103-7. PubMed ID: 484572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation].
    Vandenbroucke JP; Briët E; Helmerhorst F; van der Meer FJ
    Ned Tijdschr Geneeskd; 1995 May; 139(21):1067-71. PubMed ID: 7783798
    [No Abstract]   [Full Text] [Related]  

  • 44. [Erythema nodosum and oral contraception. Demonstration of an anti-ethinyl estradiol antibody].
    Touboul JL; Beaumont V; Meyniel D; Pieron R
    Nouv Presse Med; 1981 Feb; 10(9):712. PubMed ID: 7208317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ischemic colitis revisited: a prospective study identifying hypercoagulability as a risk factor.
    Midian-Singh R; Polen A; Durishin C; Crock RD; Whittier FC; Fahmy N
    South Med J; 2004 Feb; 97(2):120-3. PubMed ID: 14982257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. APC resistance and third-generation oral contraceptives: Acquired resistance to activated protein C, oral contraceptives and the risk of thromboembolic disease.
    Gris JC; Jamin C; Benifla JL; Quere I; Madelenat P; Mares P
    Hum Reprod; 2001 Jan; 16(1):3-8. PubMed ID: 11139527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Congenital histidine-rich glycoprotein deficiency.
    Shigekiyo T; Ohshima T; Oka H; Tomonari A; Azuma H; Saito S
    Thromb Haemost; 1993 Aug; 70(2):263-5. PubMed ID: 8236132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skin venous thromboembolism by combined oral contraceptive in a woman with acquired angioedema and Factor V Leiden mutation.
    Osmanağaoğlu MA; Okumuş B; Bozkaya H
    Contraception; 2006 Mar; 73(3):311-4. PubMed ID: 16472576
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inherited homozygous resistance to activated protein C.
    Villa P; Aznar J; Jorquera J; Mira Y; Vayá A; Fernández MA
    Thromb Haemost; 1995 Aug; 74(2):794-5. PubMed ID: 8585025
    [No Abstract]   [Full Text] [Related]  

  • 50. Ischemic colitis, pulmonary embolism, and right atrial thrombosis in a patient with inherited resistance to activated protein C.
    Ludwig D; Stahl M; David-Walek T; Brüning A; Siemens A; Zwaan M; Schmücker G; Stange EF
    Dig Dis Sci; 1998 Jun; 43(6):1362-7. PubMed ID: 9635632
    [No Abstract]   [Full Text] [Related]  

  • 51. [Screening in activated protein C resistance].
    Bergmann F
    Internist (Berl); 1997 Sep; 38(9):864. PubMed ID: 9410836
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytolytic hepatitis possibly related to levonorgestrel/ethinylestradiol oral contraceptive use: 2 case reports.
    Elouni B; Ben Salem C; Zamy M; Ganne N; Beaugrand M; Bouraoui K; Biour M
    Ann Pharmacother; 2010 Dec; 44(12):2035-7. PubMed ID: 21119102
    [No Abstract]   [Full Text] [Related]  

  • 53. Combined estrogen-progestin oral contraceptives.
    Martinelli I; Battaglioli T; Mannucci PM
    N Engl J Med; 2004 Jan; 350(3):307-8; author reply 307-8. PubMed ID: 14724315
    [No Abstract]   [Full Text] [Related]  

  • 54. [APC (activated protein C) resistance and oral contraceptives].
    Kreis I; Weiss T; Rabe TN; Ziegler R; Nawroth PP
    Geburtshilfe Frauenheilkd; 1996 May; 56(5):231-3. PubMed ID: 8768059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Giant cell thromboangiitis in a patient taking an oral contraceptive (author's transl)].
    Bakouche P; Vedrenne C; Beaumont V; Chaouat D; Reignier A; Nick J
    Rev Neurol (Paris); 1980; 136(8-9):509-19. PubMed ID: 7221328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance to activated protein C: a common anticoagulant deficiency in patients with venous leg ulceration.
    Peus D; Pittelkow MR
    Br J Dermatol; 1997 Aug; 137(2):322-3. PubMed ID: 9292102
    [No Abstract]   [Full Text] [Related]  

  • 57. [Minisiston as a contraceptive for adolescents].
    Havlín M
    Ceska Gynekol; 1997 Dec; 62 Suppl():19-20. PubMed ID: 9601711
    [No Abstract]   [Full Text] [Related]  

  • 58. Rapid disappearance of hepatic adenoma after contraceptive withdrawal.
    Aseni P; Sansalone CV; Sammartino C; Benedetto FD; Carrafiello G; Giacomoni A; Osio C; Vertemati M; Forti D
    J Clin Gastroenterol; 2001 Sep; 33(3):234-6. PubMed ID: 11500616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effective opiate-receptor antagonist therapy of cholestatic pruritus induced by an oral contraceptive.
    Kunzmann S; Kullak-Ublick GA; Greiner A; Jeschke R; Hebestreit H
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):596-9. PubMed ID: 15861022
    [No Abstract]   [Full Text] [Related]  

  • 60. Protein S deficiency, activated protein C resistance and sticky platelet syndrome in a young woman with bilateral strokes.
    Chaturvedi S; Dzieczkowski JS
    Cerebrovasc Dis; 1999; 9(2):127-30. PubMed ID: 9973658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.